The largest database of trusted experimental protocols

2 protocols using taxol t7402

1

Cholesterol Trafficking and Lysosomal Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical and standard reagents including filipin and NBD-cholesterol were obtained from Sigma-Aldrich, St. Louis, MO. LysoTracker and fluorescent dextran were obtained from Life Technologies (Grand Island, NY). shRNA constructs were obtained from SA Biosciences (Valencia, CA). Antibodies against tubulin [1:100 for immunofluorescence (IF), T6199, Sigma-Aldrich], EGFP (1:100 for IF, 632380, Clontech) and mCherry (1:100 for IF, NBP1-96752, Novus Biologicals) have been described previously (Whyte et al., 2008 (link); Towns et al., 2009 (link)). Antibodies against StARD9 [1:100 for western blotting (WB), HPA014562] were obtained from Sigma-Aldrich. Site-directed mutagenesis utilized the Phusion kit (New England Biolabs, Ipswich, MA). Antibodies against NPC1 (5 μg/ml for IF, 1 μg/ml for WB, ab108921), LAMP1 (1:10 for IF, ab25630), SREBP1 (1:100 for IF, ab28481) and cathepsin B (1 μg/ml for IF, ab6313) were obtained from Abcam (Boston, MA). filipin (f9765) was obtained from Sigma-Aldrich. NBD-cholesterol (N1148) was obtained from Invitrogen (Waltham, MA). BacMAM-ER (C10590) was obtained from Thermo Fisher Scientific (Waltham, MA). Nocodazole (M1404) and taxol (T7402) were obtained from Sigma-Aldrich. The sequences of oligonucleotides used in this study are provided in Table S3.
+ Open protocol
+ Expand
2

Chemoresistance Modulation by TGFβ1 and BMP7

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were treated with recombinant human TGFβ1 (5 ng·mL−1, PeproTech EC Ltd, London, UK) and recombinant human BMP7 (100 ng·mL−1, a gift from K. Sampath, Sanofi‐Gelisa Research Center, Framingham, MA, USA) for the time periods indicated in the Figures. The LY2157299 TβRI kinase inhibitor (Galunisertib; Sigma‐Aldrich AB, Stockholm, Sweden) was administered to cells at a final concentration of 2.5 μm. Anti‐cancer drugs, 5´‐fluoro‐uracil (5‐FU, F6627, Sigma‐Aldrich AB, Stockholm, Sweden), cisplatin (232120, Sigma‐Aldrich AB, Stockholm, Sweden), cyclophosphamide (Toronto Research Chemicals, North York, Canada), doxorubicin (D1515, Sigma‐Aldrich AB, Stockholm, Sweden) and taxol (T7402, Sigma‐Aldrich AB, Stockholm, Sweden) were used for chemoresistance experiments. Dimethyl‐sulfoxide (DMSO) served as a vehicle for all chemicals and additional details are presented in Table S3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!